3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Mixed Tumor, Mesodermal
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Head and Neck Neoplasms
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Adenoma
1
Interventions
durvalumab
8
Bevacizumab
7
tremelimumab
4
lenvatinib
3
atezolizumab
3
Nivolumab
3
Ipilimumab
3
fludarabine
2
Magnetic Resonance Imaging
2
Hepatectomy
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
toripalimab
1
ropidoxuridine
1
poly ICLC
1
pembrolizumab
1
brodalumab
1
Whole Genome Sequencing
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radionuclide Imaging
1
Pluvicto
1
Platinum
1
Paclitaxel
1
Laparoscopy
1
Immunotherapy, Adoptive
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Indocyanine Green
×
90 days
×
Clear all
No trials found.